Abstract

A RETROSPECTIVE STUDY ON CLINICAL FEATURES AND MANAGEMENT FOR COVID-19

Dr. Y. Sravani*, C. Srinitha, K. Neil Nandan, N. Manisha and Kousar Begum

.

Abstract

Background: A corona virus is a kind of common virus that causes an infection in nose, sinuses, or upper throat. Most corona viruses aren't dangerous In early 2020, after a December 2019 outbreak in China, the World Health Organization identified SARS-CoV-2 as a new type of corona virus. The outbreak quickly spread around the world. COVID- 19 is a disease caused by SARS-Chat can trigger what doctors call a respiratory tract infection. It can affect your upper respiratory tract (sinuses, nose, and throat) or lower respiratory tract (windpipe and lungs). It spreads the same way other corona viruses do, mainly through person-to-person contact. Infections range from mild to deadly. SARS-CoV-2 is one of seven types of corona virus, including the ones that cause severe diseases like Middle East respiratory syndrome (MERS) and sudden acute respiratory syndrome (SARS). Methodology: A retro prospective study was carried out involving in-patients of, general medicine, 650 bedded tertiary teaching hospital for six months. The data of 100 hundred patients were collected for the study in predefined forms from the medical case records and drug charts. Descriptive statistics were applied to the collected data and analyzed using Microsoft Excel software. Results: The most common symptoms in covid patient were fever, cough, sob, headache, chills. males were more symptomatic than females in case of fever, sob, cough, clod, chills, headache, loose stools, vomiting, loss of appetite, loss of smell taste. Females were more symptomatic in body pains, dryness of throat. commonly used treatment in covid patients are antibiotics, antiviral, multivitamins, ppi’s, steroids, antipyretics, anticoagulants. Commonly prescribed antibiotics were macrolides (azithromycin, doxycycline, ceftriaxone), antivirals were fabiflu, fabizapire. Conclusions: Our study concludes majority of patients presents with fever, respiratory features (like cough, sob, cold) sore throat, headache, loss of appetite etc. The reviews show 1% people were asymptomatic, Major modalities of management includes antibiotic, antiviral and steroid therapy having no direct relationship between the specific treatment and the outcome.

Keywords: antibiotics, antivirals, covid-19(SARS-CoV-2), (MERS) Middle east respiratory syndrome.